GUTS

Insider Trades

Name	Value	Action	Price	Current Price
Smith Weber LaraChief Financial Officer $14k20k shares BuyJun 8, 2026 $0.6854 $0.8371
Rajagopalan HarithDirector, Officer: Chief Executive Officer $20k10.4k shares BuyDec 4, 2025 $1.92 --

News

globenewswire.comFractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedureglobenewswire.comJun 4

globenewswire.comFractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial Strategyglobenewswire.comJun 1

seekingalpha.comFractyl Health, Inc. (GUTS) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.comMay 14

seekingalpha.comFractyl Health, Inc. (GUTS) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 12

marketbeat.comFractyl Health Q1 Earnings Call Highlightsmarketbeat.comMay 12

Trade GUTS

About Fractyl Health, Inc. Common Stock

Fractyl Health, Inc. is a biopharmaceutical firm dedicated to advancing treatments for type 2 diabetes (T2D) and obesity. Among its offerings is the Revita DMR System (Revita), an outpatient procedure engineered to provide lasting modification of duodenal dysfunction. This condition often arises from diets high in fat and sugar, playing a role in the onset of T2D and obesity in individuals. Fractyl Health is also pioneering Rejuva, an innovative gene therapy platform utilizing a viral delivery system directly to the pancreas. Rejuva's objective is to achieve long-term remission from T2D and obesity by fundamentally altering metabolic hormone function within patients' pancreatic islet cells. Incorporated in 2010, the company, formerly known as Fractyl Laboratories Inc., officially became Fractyl Health, Inc. on June 9, 2021. Its operations are headquartered in Lexington, Massachusetts.

CEO: Harith Rajagopalan
IPO Date: Feb 2, 2024

Market Data

Open: $0.8722
High: $0.8999
Low: $0.8286
Volume: 1.4M
Avg Volume: 2.2M
52W High: $2.45
52W Low: $0.377

Valuation

Market Cap: $62M
Enterprise Value: $60M
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-91M
Revenue: $0
Net Income: $-141M
Cash: $82M
Debt: $62M

Events

EarningsAug 11

EPS est. -0.15